Molnupiravir is now authorised in the UK by the Medicines and Healthcare Products Regulatory Committee.

It may be given to patients most at risk of poor outcomes from covid, such as older adults with other serious illnesses.

It's to be hoped that generic versions of the drug will also be available to countries such as the Philippines.